Middle East Pharmaceutical Industries Company
4016.SRSAUHealthcare● Active
$62.10
$-0.20(-0.32%)
Market Cap$2.2B
P/E Ratio—
52W High$79.08572
52W Low$53.88572
Middle East Pharmaceutical Industries Company (4016.SR) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4016.SR · as of 2026-06-16
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.03B | $0.02B | $0.02B | $0.02B | $0.02B |
| Net Receivables | $0.26B | $0.22B | $0.16B | $0.16B | $0.17B |
| Inventory | $0.10B | $0.09B | $0.09B | $0.10B | $0.08B |
| Total Current Assets | $0.41B | $0.36B | $0.28B | $0.29B | $0.27B |
| PP&E Net | $0.12B | $0.12B | $0.12B | $0.11B | $0.10B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.06B | $0.05B | $0.05B | $0.04B | $0.03B |
| Total Assets | $0.60B | $0.53B | $0.44B | $0.44B | $0.42B |
| Liabilities | |||||
| Short-Term Debt | $0.04B | $0.07B | $0.06B | $0.08B | $0.07B |
| Accounts Payable | $0.04B | $0.03B | $0.03B | $0.04B | $0.03B |
| Total Current Liabilities | $0.13B | $0.13B | $0.11B | $0.13B | $0.12B |
| Long-Term Debt | $0.02B | $0.00B | $0.00B | $0.01B | $0.02B |
| Total Liabilities | $0.18B | $0.16B | $0.14B | $0.16B | $0.15B |
| Stockholders Equity | |||||
| Retained Earnings | $0.23B | $0.18B | $0.13B | $0.08B | $0.20B |
| Total Stockholders Equity | $0.42B | $0.37B | $0.31B | $0.28B | $0.27B |
| Total Liab & Equity(computed) | $0.60B | $0.53B | $0.44B | $0.44B | $0.42B |
| Debt Summary | |||||
| Total Debt | $0.06B | $0.07B | $0.06B | $0.08B | $0.09B |
| Net Debt | $0.03B | $0.04B | $0.04B | $0.06B | $0.07B |
Data source: Financial Modeling Prep · Last updated: 2026-06-16 · SAR · B
Explore more Middle East Pharmaceutical Industries Company data
About Middle East Pharmaceutical Industries Company (4016.SR) Balance Sheet
Middle East Pharmaceutical Industries Company (4016.SR) balance sheet shows total assets of $0.60B with cash of $0.03B. Total liabilities are $0.18B, total debt $0.06B, and stockholders equity $0.42B.
Frequently asked questions
4016.SR · 4 questionsMiddle East Pharmaceutical Industries Company has total debt of $0.06B with net debt of $0.03B.
4016.SR total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-16